Get the Stockscreener App
32.43
0.23%
-0.04
Medifast Inc stock is currently priced at $32.43, with a 24-hour trading volume of 179.52K.
It has seen a -0.23% decreased in the last 24 hours and a -7.29% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $32.28 pivot point. If it approaches the $32.85 resistance level, significant changes may occur.
Medifast Inc Stock (MED) Financials Data
Medifast Inc (MED) Revenue 2024
MED reported a revenue (TTM) of $1.07 billion for the quarter ending December 31, 2023, a -32.94% decline year-over-year.
Medifast Inc (MED) Net Income 2024
MED net income (TTM) was $99.41 million for the quarter ending December 31, 2023, a -30.75% decrease year-over-year.
Medifast Inc (MED) Cash Flow 2024
MED recorded a free cash flow (TTM) of $141.17 million for the quarter ending December 31, 2023, a -20.64% decrease year-over-year.
Medifast Inc (MED) Earnings per Share 2024
MED earnings per share (TTM) was $9.06 for the quarter ending December 31, 2023, a -28.72% decline year-over-year.
Medifast Inc Stock (MED) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SCHLACKMAN SCOTT | Director |
Mar 08 '24 |
Sale |
39.44 |
4,053 |
159,866 |
7,785 |
| BROWN JEFFREY J | Director |
Nov 07 '23 |
Buy |
68.89 |
58 |
4,020 |
5,784 |
| SCHLACKMAN SCOTT | Director |
Nov 07 '23 |
Buy |
68.89 |
53 |
3,627 |
10,538 |
| Thomas Andrea B | Director |
Nov 07 '23 |
Buy |
68.89 |
50 |
3,471 |
6,253 |
| Hoer Michael A. | Director |
Nov 07 '23 |
Buy |
68.89 |
50 |
3,428 |
8,375 |
| BROWN JEFFREY J | Director |
Nov 03 '23 |
Buy |
70.55 |
97 |
6,825 |
4,233 |
| HALLQUIST CONSTANCE J. | Former Director |
Oct 06 '23 |
Sale |
73.87 |
5,613 |
414,632 |
2,152 |
| BROWN JEFFREY J | Director |
Aug 15 '23 |
Sale |
90.18 |
23,162 |
2,088,780 |
1 |
| BROWN JEFFREY J | Director |
Aug 14 '23 |
Sale |
92.60 |
15,154 |
1,403,260 |
23,163 |
| BROWN JEFFREY J | Director |
Aug 08 '23 |
Buy |
89.42 |
44 |
3,947 |
5,725 |
Medifast Inc Stock (MED) Latest News
Medifast's (MED) Transformation on Track Amid Macro Headwinds
Zacks Investment Research
MEDIFAST (MED) Down 11.5% Since Last Earnings Report: Can It Rebound?
Zacks Investment Research
Medifast (MED) Soars 5.9%: Is Further Upside Left in the Stock?
Zacks Investment Research
Innovations Aid Medifast (MED), Lower Customer Attraction Ails
Zacks Investment Research
Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
Medifast (MED) Q4 Earnings Beat Estimates, Revenues Dip Y/Y
Zacks Investment Research
About Medifast Inc
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products. It offers bars, bites, pretzels, puffs, oatmeal and cereal crunch products, drinks, hearty choices, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by OPTAVIA, Flavors of Home, and Essential 1 brands. The company sells its products through various channels, including the Internet, call centers, independent health advisors, medical professionals, franchise weight loss clinics, and direct consumer marketing. As of December 31, 2017, it operated 16 franchised Medifast weight control centers in Arizona, California, Louisiana, Minnesota, and Wisconsin; and 18 reseller locations in California, Maryland, and Pennsylvania. The company was founded in 1980 and is headquartered in Baltimore, Maryland.
COMPANY PROFILE
NameMedifast Inc
SectorConsumer Cyclical (570)
IndustryPersonal Services (18)
Web
Phone410-581-8042
Employee399
Twitter
@optavia_tweets
SEC filings
Latest SEC Filings
Next earning date2024-04-29
Address100 International Drive, Baltimore, MD, United States (21201)
1.99%
Cap:
|
Volume (24h):